Rapport Therapeutics, Inc. Common Stock (RAPP)

10.27

(0.88%)

Annual Income Statements

(In USD)
Breakdown 2023 2022
Revenue - -
Cost of Revenue 112 Thousand 15 Thousand
Gross Profit -112 Thousand -15 Thousand
Operating Expenses 36.06 Million 10.35 Million
Selling, General and Administrative Expenses 8.06 Million 1.23 Million
Research and Development Expenses 27.99 Million 9.11 Million
Other Expenses - -
Cost and Expenses 36.17 Million 10.36 Million
Operating Income -36.17 Million -10.36 Million
Interest Expense - 285 Thousand
Income Tax Expense 10 Thousand -
Earnings before Tax -34.77 Million -10.65 Million
Net Income -34.78 Million -10.65 Million
Earnings Per Share Basic -0.21 -0.29
Earnings Per Share Diluted -0.21 -0.29
Weighted Average Shares Outstanding 164.35 Million 36.57 Million
Weighted Average Shares Outstanding (Diluted) 164.35 Million 36.57 Million
Gross Margin - -
EBIT Margin - -
Profit Margin - -
EBITDA -34.66 Million -10.35 Million
Earnings Before Tax Margin - -

Income Statement Charts